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highly conserved element found in the promoter region of photoreceptor-speciﬁc genes such as rhodopsin
and red cone opsin. We verify that Rx is co-expressed with rhodopsin and red cone opsin in maturing
photoreceptors and demonstrate that Rx binds to the rhodopsin and red cone opsin promoters in vivo. We
also ﬁnd that Rx can cooperate with the Xenopus analogs of Crx and Nrl, otx5b and XLMaf (respectively), to
activate a Xenopus opsin promoter-dependent reporter. Finally, we demonstrate that reduction of Rx
expression in tadpoles results in decreases in expression of several PCE-1 containing photoreceptor genes,
abnormal photoreceptor morphology, and impaired vision. Our data suggests that Rx, in combination with
other transcription factors, is necessary for normal photoreceptor gene expression, maintenance, and
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The retinal homeobox (Rx) gene is essential for vertebrate eye
development (reviewed in Bailey et al., 2004). It is expressed in the
prospective eye ﬁeld at neural plate stages, prior to the appearance of
morphological evidence of eye development (Casarosa et al., 1997;
Chen and Cepko, 2002; Deschet et al., 1999; Furukawa et al., 1997a;
Mathers et al., 1997; Ohuchi et al., 1999). Loss of Rx function results in
severe reduction, or complete lack, of eye development in a variety of
vertebrate species (Andreazzoli et al., 1999; Chen and Cepko, 2002;
Chuang and Raymond, 2001; Loosli et al., 2003, 2001; Mathers et al.,
1997; Voronina et al., 2004) while over-expression of Rx results in
development of extra retinal tissue (Andreazzoli et al., 1999; Chuang
and Raymond, 2001; Mathers et al., 1997). Xenopus neural retinal cells
forced to express Rx can develop into any retinal cell type, suggestingthat Rx functions tomaintain cells in a pluripotent state without biasing
cell fate (Casarosa et al., 2003). Inmouse, retinal cells expressingRx tend
to develop intoMuller glial cells, a cell type that is thought to be capable
of de-differentiating to provide a source of progenitors in the mature
retina (Furukawa et al., 2000). Taken together, these results establish
the importance of Rx in retinal development and suggest that Rxmay be
involved in regulating speciﬁcation and proliferation of retinal
progenitor cells. However, Rx is also expressed in photoreceptors in
the mature retina (Perron et al., 1998). In zebraﬁsh, knockdown of Rx1
and Rx2 during retinal maturation results in attenuation in photore-
ceptor development (Nelson et al., 2009). The molecular details of Rx
function in these differentiated cells have not been determined.
The Rx gene product has been shown to function as a weak
transcriptional activator. First, a constitutive repressor form of Rx (a
fusion with the engrailed repression domain) functions as an
antimorph, suggesting that Rx normally functions as a transcriptional
activator (Andreazzoli et al., 1999). Second, Rx has been shown to
bind a sequence element known as Photoreceptor Conserved Element
1 (PCE-1; also known as Ret1) (Kimura et al., 2000), a conserved
sequence element found in promoters of many genes expressed in
photoreceptors, including rhodopsin (rho), red cone opsin (RCO), rod
arrestin, and interphotoreceptor retinoid-binding protein (IRBP) genes
(Batni et al., 1996; Boatright et al., 1997; Kikuchi et al., 1993; Ma et al.,
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highly conserved among vertebrates and has been analyzed in detail
(Ma et al., 2001). Rx weakly activates synthetic gene reporter
constructs containing multiple copies of PCE-1 (Chen and Cepko,
2002; Kimura et al., 2000). In addition to the PCE-1 site, rho promoters
contain three additional conserved cis-acting elements, the BAT
(Ret2), NRE (Ret3), and Ret4 sites. The BAT and Ret4 sites contain
consensus core homeobox protein binding motifs. The BAT site
primarily binds members of the orthodenticle (otx) family of
transcription factors (Kimura et al., 2000), such as otx2 and cone-
rod homeobox (crx) or its analog otx5b (Whitaker and Knox, 2004).
Rx can also bind the BAT site, although it has greater afﬁnity for the
PCE-1 site (Kimura et al., 2000; Pan et al., 2006; Wang et al., 2004).
NRE is the binding site for the transcription factor neural retina
leucine zipper (Nrl) or its Xenopus analog XLmaf (Ishibashi and
Yasuda, 2001). It has been well established that crx and Nrl synergize
to activate rho promoters (Chen et al., 1997; Mitton et al., 2000), as do
the Xenopus analogs otx5b and XLmaf (Whitaker and Knox, 2004).
Additionally, transcription factors of the zinc ﬁnger (Sp4, KLF15) and
nuclear hormone receptor (Nr1d1, Nr2e3) families are also involved
in regulating rho promoters (Cheng et al., 2004; Lerner et al., 2005;
Otteson et al., 2005, 2004). The function of Rx has not been
characterized in the context of an intact PCE-1-containing promoter
such as the rho promoter.
Here we verify that Rx is expressed in rhodopsin-positive
photoreceptors of the maturing retina. We report that Xenopus laevis
Rx can speciﬁcally bind PCE-1-containing promoters in vivo, including
rho and RCO. Further, we show that Rx can activate the Xenopus opsin
promoter (XOP) in functional cooperation with XLmaf and otx5b.
Finally, we demonstrate that expression of several photoreceptor-
speciﬁc genes and photoreceptor development and function are
dependent on Rx expression.
Materials and methods
Embryos
Embryos were produced by in vitro fertilization (Sive et al., 2000).
Transgenic embryos were generated by intracytosolic sperm injection
(ICSI) (Sparrow et al., 2000). For experiments involving injection of
RNA into transgenic embryos, eggs were injected with sperm nuclei
and transgene (ICSI). Dividing embryos were subsequently injected
with RNA into one blastomere at 4-cell stage. Embryos were then
screened for transgenesis markers and RNA lineage tracers at
appropriate stages.
Plasmids
We have described the preparation of XOP-Luc and pCS2/RxL
previously (Pan et al., 2006). To prepare MT-Rx, the Rx coding regionTable 1
Primers used for quantitative PCR.
Gene Forward primer
Rx1A GCACAAGTTGGGCATAGTAGGG
Rx2A CCGTGAGCCACATTCAAATCTA
L8 AAGCTTCGGGCTATCGACTTT
Rhodopsin TCCTGATCTGTTGGGTGCC
RCO TTTCCGCAAAGCAAAATGG
silver CAATAAATGAGCTGCCCGG
XOP TCAGACCTGGATTTCTTCCTGT
RCO pro GGGTGGACGTTAAAACTCATATGC
Rho exon5 CTGCTTGATCACCACCCTGTG
RCO UTR GTAGTTACGCCCCTGGTGATG
Rx shRNA GATCAAGCTTCTATACTGTGCAGCCTTGAT
IRBP TCCTCGCCTGGTTGTCTCCTAT
arrestin TTCCCTGATTTCTTGCCATGC(starting with the second codon) was ampliﬁed from pSP64T/Rx1A
(Mathers et al., 1997) and subcloned into compatible sites in pCS2 +
MT (Turner and Weintraub, 1994). DsRedExpress RNA was prepared
from pCS2/HA-dsRedExpress (Seufert et al., 2005). The PCE-1 site was
mutated in XOP-GFP (Mani et al., 2001) using the QuickChange XL Site
Directed Mutagenesis Kit (Stratagene) and the primer 5′-
CGTTTAAGGGAAGCCAGCTGACACTTTGCAATTTTAGCTTGG-3′ and its
reverse complement, based on a previously described mutagenesis
of the PCE-1 site (Kimura et al., 2000). XOP-dsRed was prepared by
liberation of XOP from XOP-GFP (digested using BglII and BamHI) and
insertion into pL-dsRed (digested using BamHI). pL-dsRed was
prepared by liberation of the dsRed coding region and SV40 poly(A)
signal from pCS2/HA-dsRedExpress and insertion into pLITMUS29
(New England Biolabs) (both digested using HinDIII and NsiI).
The Rx shRNA was designed using the RNAi OligoRetriever
program with the Shagging-pSHAG1 BseRI–BamHI new design
method (URL: http://katahdin.cshl.org:9331/RNAi/html/rnai.html)
(Paddison and Hannon, 2002). The coding sequences for Rx1A or
Rx2A (Mathers et al., 1997) were individually entered in the program
to design an shRNA oligonucleotide that was identical for both Rx1A
and Rx2A. The shRNA template was generated by PCR using the full-
length oligonucleotide sequence 5′-GATCAAGCTTCTATACTGTG-
CAGCCTTGATGGGTTACCTTTGGAGGTAACCCATCAAGGCTGTACAGTA-
TAGTTTTTTGGATCCAAGCTTGATC-3′. The shRNA second strand was
generated and the double-stranded oligonucleotide was ampliﬁed for
using Pfx (Invitrogen) and the primers shown in Table 1. The 94 bp
PCR product was TA cloned in pCR2.1 (Invitrogen) and sequenced to
conﬁrm that point mutations were not introduced during PCR. The
double-stranded oligonucleotide was then subcloned into a modiﬁed
pRNAT vector (Genscript) containing the X. laevisU6 promoter (Li and
Rohrer, 2006) using HinDIII sites included in the oligonucleotide
sequence (underlined). Orientation was determined using a BamHI
site adjacent to one of the HinDIII sites (bold). As a control, an shRNA
template encoding a reversed target sequence was similarly obtained
and cloned. shRNA transgenes were prepared by restriction endonu-
clease digestion using BglII, PstI and SalI to release a 3 kb fragment.
The X. laevis ortholog of the silver gene was ampliﬁed from
X. laevis tadpole head cDNA by degenerate RT-PCR (accession number
FJ643547).
The mRx rescue construct was prepared in several steps. First, the
mRx coding region (Mathers et al., 1997) was ampliﬁed by PCR using
appropriate primers and cloned into pCS2 (EcoRI and XhoI, contained
in primers). Second, a 3 kb region of DNA adjacent to the Rx coding
region was ampliﬁed from Xenopus tropicalis genomic DNA
(corresponding to scaffold_228:571,277–574,283 of X. tropicalis
genome August, 2005, assembly) using speciﬁc primers and cloned
into pBlueScript II KS (BamHI and EcoRV, contained in primers) to
make pBS/tRx3000. UCE2 (scaffold_228:579,112–579,379), was
similarly ampliﬁed, digested (BamHI and BglII) and cloned into pBS/
tRx3000 (BamHI) to make pBS/UCE2 + tRx3000. Third, the dsRedReverse primer
GTTTTTGGGAAAGCTGGGC
AATACCAATCACAGCGCCCCT
ACGGCCTGGATCATGGATAA
TGAAGACTGGGCCAAAGTCG
GTAGTTACGCCCCTGGTGATG
AATAACCACAACCTCCTCGGC
ATTGCAAAGTGTTAATTGGCTTC
GCTCAGCTGGATTAGCCTAGACAC
TCTGTCTTGGAGGTGGCTGC
TTTCCGCAAAGCAAAATGG
G GATCAAGCTTGGATCCAAAAAACTATACTGTAC
AGCTGTTCCGGTGTTAGCTCCA
TTCAAAATCCACACCACAGGC
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pCS2 + HA/dsRedExpress in two fragments (a SalI and KpnI fragment
and a KpnI fragment) and cloned into pBS/UCE2 + tRx3000 (digested
with SalI and KpnI) in two steps (ﬁrst the SalI + KpnI fragment and
then the KpnI fragment) to make UCE2 + tRx3000 + dsRed. Finally,
the mRx coding region and SV40 poly(A) signal were excised from
pCS2/mRx (HinDIII and NotI and blunt-ended using the Klenow
fragment of DNA polymerase) and introduced into UCE2+ tRx3000+
dsRed (EcoRV) to make the mRx rescue transgene plasmid. The mRx
rescue transgene was prepared by digestion of the plasmid with
NotI.
A full-length Argonaute2 cDNA clone was identiﬁed as encoding Xl
eIF2C (NCBI UniGene Xl.43287) in Sport6 was obtained from Open
Biosystems (catalogue numberMXL1736-9506800; accession number
BC077863). The coding region was ampliﬁed by PCR using the
following primers XL-eIF2C-F: 5′- GAATTCCATGTACTCCGGGGCC-3′;
XL-eIF2C-R: 5′-GAATTCAAGTCACTGGATAAACAGCGG-3′ to introduce
EcoRI sites (underlined) and subcloned into the TOPO 2.1 vector
(Invitrogen) by TOPO TA cloning. Ago2 was then subcloned into the
EcoRI site of pCS2 + MT. Transformants were checked for insertion
and orientation by colony PCR and conﬁrmed by sequencing.
Synthetic mRNA was prepared by linearization with NotI and in
vitro transcription using the mMessage mMachine SP6 in vitro
transcription kit (Ambion).
Histology, in situ hybridization and immunohistochemistry
Antisense riboprobes were prepared by in vitro transcription as
described previously for Rx, rhodopsin, and red cone opsin (Liu et al.,
2001; Mathers et al., 1997; Mathers and Jamrich, 2000; Pan et al.,
2006). In situ hybridization using whole or sectioned embryos was
performed as described previously (Sive et al., 2000; Viczian et al.,
2003). Staining of parafﬁn sections with antibodies was performed as
previously described (El-Hodiri et al., 1997). Primary antibodies were
used at the following dilutions: mouse anti-rhodopsin (RetP1,
Biomeda) 1:50; mouse anti-islet1, 1:50 [39.4D5, Developmental
Studies Hybridoma Bank (DSHB), University of Iowa]. Biotinylated-
peanut agglutinin (Vector) was used at 5 μg/ml.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed using a
combination of protocols from the Farnham (URL: http://www.
genomecenter.ucdavis.edu/farnham/protocols/tissues.html) (Wells
et al., 2002) and Young labs (URL: http://jura.wi.mit.edu/young_
public/hESregulation/ChIP.html) (Boyer et al., 2005). Brieﬂy, 4-celled
embryos were cultured from in vitro fertilized eggs (Sive et al., 2000)
and injected with 10 pgmyc-tagged Rx (MT-Rx) or 1 pg myc tag (MT)
RNA into both prospective dorsal blastomeres. Abnormally develop-
ing embryos were discarded. Embryos were cultured to st 41
(Nieuwkoop and Faber, 1994) and anesthetized by immersion in
MS222. Embryos were then collected and washed in Embryo Wash
Buffer [0.03% (v/v) Triton X-100, 100 mM NaCl, 1× Roche Mini-
Complete Protease Inhibitors] and ﬁxed for 15 min in Crosslinking
Buffer [50 mM HEPES (pH 8), 1 mM EDTA, 0.5 mM EGTA, 100 mM
NaCl, 1.8% (w/v) formaldehyde] at room temperature. Crosslinking
was halted by addition of glycine to 0.125 M and incubation for 5 min
at room temperature. Embryos were then washed in phosphate-
buffered saline containing 10 mM EDTA and 0.1% (v/v) Tween-20
(PBSE-Tw). Embryo headswere isolated and homogenized in 2ml Cell
Lysis Buffer. Nuclei were pelleted by centrifugation. Pellets were
resuspended in 2 ml Nuclei Lysis Buffer, transferred to 15 ml conical
tubes ﬁtted with ultrasound reﬂecting bars, and sonicated in a water
bath sonicator (Diagenode Bioruptor) for 12 min (30 s on/30 s off) at
“High” power setting. Lysates were incubated overnight at 4 °C with
rabbit IgG (Upstate) or polyclonal antibodies raised to the mycepitope tag (Sigma) prebound to Protein G magnetic beads (Dynal),
prepared as described (Boyer et al., 2005). DNA was recovered
following reversal of crosslinking, puriﬁed and used as template for
real-time PCR. Real-time PCR was performed in a 25-μl ampliﬁcation
mixture containing 1 μl of ChIP product, 12.5 μl of 2× PCR master mix
(SYBR Green; Applied Biosystems, Foster City, CA), and 100 nM
forward and reverse primers, respectively (Table 1). The PCR
conditions included a polymerase activation step at 95 °C for 10 min
followed by 50 cycles of 95 °C for 15 s and 60 °C for 60 s and run on a
sequence detector (Model 7500; Applied Biosystems). The CT for XOP
or RCO promoter was normalized by the CT of the rabbit IgG control.
The statistical signiﬁcance of relative differences in expression levels
was determined by Student's group t-test.
Quantitative RT-PCR
Total RNAwas extracted from the isolated heads of individual st 41
tadpoles using Trizol according to manufacturer's protocol and
treated with DNase I to eliminate genomic DNA contamination.
cDNA was prepared from RNA template by reverse transcription (RT)
using qScript cDNA SuperMix (Quanta BioSciences) in a 20 μl reaction,
according to manufacturer's directions. Quantitative (real-time) PCR
was performed in a 25 μl ampliﬁcation mixture containing 1 μl of
cDNA product, 12.5 μl of 2× SYBR Green PCR master mix (Applied
Biosystems), and 100 nM forward and reverse primers speciﬁc to each
gene and PCR conditions as described for ChIP, above. A housekeeping
gene, L8, was used as an internal control. The statistical signiﬁcance of
relative differences in expression levels was determined by Student's
group t-test.
Luciferase assays
Embryos were injected at 2-cell stage with 25 pg XOP-Luc DNA
(Pan et al., 2006), pRLtkLuc (encoding Renilla luciferase as an internal
control) and RNAs encoding effectors as indicated in the ﬁgure
legends. Embryo lysates were prepared at st 11 and assayed for
luciferase activity using the Stop n Glo Dual Luciferase Assay Kit
(Promega) as described previously (Kelly et al., 2006; Pan et al., 2006).
Fireﬂy luciferase activity values were normalized against Renilla
luciferase activity values and presented as fold activation compared to
the baseline activity of the reporter (without co-injected effectors).
Transgenesis
Transgenes were digested with appropriate restriction endonu-
cleases and puriﬁed from an agarose gel (GeneClean Kit, Bio101),
unless indicated otherwise. Transgene concentration was determined
by direct comparison of puriﬁed transgene to a DNA mass ladder
(Invitrogen) resolved by agarose gel electrophoresis. Transgenic X.
laevis embryos were prepared by intracytosolic sperm injection (ICSI)
as described previously (Sparrow et al., 2000) using digitonin-treated
sperm nuclei (Huang et al., 1999). Embryos transgenic for the pRNAT
plasmid (shRNA transgenics) were identiﬁed by observation of blue
ﬂuorescence (from the cGFP expression cassette). Embryos transgenic
for the mRx rescue plasmid were identiﬁed by observation of red
ﬂuorescence (from the dsRed Express expression cassette). Fluores-
cence in live embryos was observed using a Leica MZFLIII ﬂuorescent
microscope with a GFP2 ﬁlter. Digital images were captured using a
SPOT RT SE 7.2 Color Mosaic digital camera (Diagnostic Instruments).
Quantitation of ﬂuorescence
Fluorescence in photomicrographs was quantiﬁed essentially as
described previously (Ghai et al., 2009). Tadpoles were generated
cotransgenic for XOP-dsRed containing a wild-type or mutated PCE-1
site and Rx or control shRNA. As discussed above, the shRNA
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cultured to st 41, ﬁxed, and cryopreserved. Sections were cut at 10 μM
thickness and mounted using Vectashield Hard Set with DAPI (Vector
Labs). All photomicrographs were captured by a SPOT RT digital
camera connected to a Nikon Eclipse E800 microscope using identical
exposure times (10 s). Fluorescence was quantiﬁed using IMAGEPRO
6.2 software (Media Cybernetics, Bethesda, MD, USA). For each image,
the whole retina area was selected. Green or red cells or cell clusters
were picked automatically by program by adjusting intensity value for
each color, threshold (0=black, 255=saturated green or red).
Threshold was set to cover all the labeled cells in the retina. The
average pixel intensity was calculated for all pixels within threshold
regions. These calculations were determined for each retinal region
sampled from two to three different embryos for each experiment
conditions. Red ﬂuorescence values (XOP-dsRed readout) were
normalized to green ﬂuorescent values (as a measure of the shRNA
transgene). Values are presented as average normalized ﬂuorescence
values±standard deviation. Statistical analysis was performed using
Student's group t-test.
Tadpole visual function assay
Tadpoles were tested for visual system function essentially as
described previously (Moriya et al., 1996). Tadpoles were raised to stFig. 1. Rhodopsin and red cone opsin (RCO) are Rx targets. (A–C) Rx is co-expressed with
embedded st 41 tadpoles using probes for Rx (A), rhodopsin (B) or RCO (C). (D, E) Chromatin
the rhodopsin (D) and RCO (E) promoters in vivo. Results are presented as the CT of each sa45 or 50 and kept on a white background for at least 3 days. Tadpoles
were then placed into a 4″×6″×3″ clear colorless plastic container
containing approximately 500 ml 0.1× MMR. This container was
placed inside a slightly larger container, half covered with black paper
and half covered with white paper. Tadpoles were introduced singly
into the container. Their position (white half or black half) was
recorded after 2min. This test was repeated 5–10 times on each of two
consecutive days.
Results
It has been reported that Rx binds the highly conserved
photoreceptor conserved element (PCE-1) found in the regulatory
regions of many genes expressed in photoreceptors (Boatright et al.,
1997; Kikuchi et al., 1993; Ma et al., 2001; Mani et al., 2001). Previous
reports have focused on the striking expression of Rx in the anterior
neural plate and during early phases of eye speciﬁcation and retinal
development, prior to differentiation of photoreceptors. To determine
if PCE-1 site-containing promoters may be targets of Rx, we ﬁrst asked
if Rx expression overlaps the expression of photoreceptor-speciﬁc
genes, such as rhodopsin (rho) and red cone opsin (RCO). There are two
Rx genes in X. laevis, Rx1A and Rx2A (Mathers et al., 1997) with
apparently identical expression patterns (unpublished data). Rx1A
has been reported to be expressed weakly in the photoreceptor layerrhodopsin and RCO in photoreceptors. In situ hybridization on sections from parafﬁn-
immunoprecipitation (ChIP) results indicating that myc-tagged Rx (MT-Rx) can bind to
mple normalized to the CT of a “no antibody” control. ⁎pb0.003 (XOP), pb0.002 (RCO).
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X. laevis Rx1A promoter-GFP transgene is expressed in both rods and
cones and zebraﬁsh Rx1 is expressed in rods and cones (Chuang et al.,
1999; Nelson et al., 2008; Zhang et al., 2003). We veriﬁed that Rx1A is
expressed in the mature Xenopus retina (st 41), primarily in the
marginal zone and photoreceptor layer (Fig. 1A). Importantly, genes
regulated by PCE-1-dependent promoters are also expressed in the
photoreceptor layer, such as rho and RCO (Figs. 1B, C). These results
conﬁrm the expression of Rx1A in photoreceptor cells where PCE-1-
dependent genes are expressed. Thus, genes regulated by promoters
containing PCE-1 sites are biologically relevant potential Rx targets.
The Xenopus opsin promoter (XOP) regulates transcription of the
rho gene in rod photoreceptors and contains a highly conserved
PCE-1 element (Batni et al., 1996; Mani et al., 2001). Since Rx1A is
expressed in photoreceptors and can bind the PCE-1 site, we selected
XOP as a putative Rx1A target. We asked if Rx1A can bind to XOP in
vivo by chromatin immunoprecipitation (ChIP).We have not found an
antibody that reliably immunoprecipitates Xenopus Rx (YP, SN, LEK,
and HME, unpublished). Therefore, we expressed a myc-tagged Rx1A
(MT-Rx) in Xenopus embryos and performed ChIP using an antibody
raised against the myc tag. As a control, we expressed myc-tag (MT)
alone. XOP chromatin was not precipitated from embryos expressing
MT only (Fig. 1D). We found that the anti-myc antibody speciﬁcally
precipitated chromatin containing XOP when MT-Rx was expressed
(Fig. 1D). A rho coding exon was not efﬁciently precipitated from
embryos expressing MT-Rx (Fig. 1D). Additionally, a non-PCE-1
containing promoter, the Rx2A promoter, was not precipitated by
MT-Rx (not shown). Taken together, these results demonstrate that
Rx can speciﬁcally bind the rho promoter in vivo. Further, the
antibody could precipitate chromatin that included another PCE-1-
containing gene regulatory region, the promoter of the red cone opsin
(RCO) gene (Fig. 1E) (Moritz et al., 2002). These ChIP results
demonstrate that Rx1A can bind to PCE-1 containing promoters in
vivo. Speciﬁcally, these results demonstrate that Rx can bind
regulatory regions of photoreceptor-speciﬁc genes in the differen-
tiating retina and retina-derived cells in vivo.
To investigate the function of Rx1A in regulating transcription, we
tested its ability to activate a luciferase reporter gene construct
containing XOP. We found that Rx1A could indeed activate thisFig. 2. Rx and RxL can cooperate with other factors to activate the Xenopus opsin promoter (
reporter plasmid and Rx, Rx-L, otx5b, and/or XLmaf RNAs as shown. (A) Rx activates XOP-Lu
XOP-Luc reporter. (C) Rx-L cooperates with otx5b and XLmaf to activate the XOP-Luc reporeporter in a dose-dependent manner, albeit weakly (Fig. 2A). Rho
promoters are activated, in part, by synergistic interactions between
the crx and Nrl transcription factors (Chen et al., 1997; Mitton et al.,
2000;Whitaker and Knox, 2004). Binding sites for these proteins (BAT
and NRE, respectively) are well conserved in rho promoters (Chen et
al., 1997; Ma et al., 2001; Mani et al., 2001; Mears et al., 2001),
including XOP. XOP can be activated by mammalian crx and Nrl and
by the analogous Xenopus proteins, otx5b and XLmaf (Ishibashi and
Yasuda, 2001), also known as XLNrl. To investigate the possibility that
Rx can cooperatively activate XOP, we tested the activity of Rx1A on
XOP in the presence of otx5b and XLmaf. We found that otx5b and
XLmaf synergistically activated XOP in our experimental system and
that Rx1A cooperated with these factors to further activate XOP
(Fig. 2B).
We have previously characterized Rx-like gene product, Rx-L, that
contains a homeodomain that is nearly identical to the Rx home-
odomain but does not contain an octapeptide motif (OP) (Pan et al.,
2006). It has been demonstrated that the chicken and human Rx-like
gene products, cRaxL and QRX, bind the PCE-1 site and are stronger
transcriptional activators than Rx gene products, presumably because
they lack an OP (Chen and Cepko, 2002; Wang et al., 2004). It has also
been shown that QRX can cooperate with CRX and NRL to activate a
rhodopsin promoter-based reporter gene (Wang et al., 2004). To
determine whether Rx-L functioned similarly, we tested its ability to
activate the XOP-Luc reporter in our experimental system. We found
that the combination of Rx-L, otx5b, and XLmaf activated the XOP-Luc
reporter to a greater degree than either Rx-L alone or the combination
of otx5b and XLmaf (Fig. 2C), suggesting that Rx-L can also
functionally cooperate with otx5b and XLmaf to activate XOP.
We next investigated the involvement of Rx gene products in
regulating rho and RCO gene expression in vivo. We used a shRNA-
based approach to knock down Rx expression during embryonic
development. Oligonucleotides encoding an Rx-speciﬁc shRNA were
produced and introduced into a modiﬁed version of the pRNAT
plasmid. This allowed us to prepare transgenic embryos ubiquitously
expressing the Rx shRNA under the control of the X. tropicalis U6
promoter. The Rx shRNA matched 29 nucleotides of the Rx1A
transcript and 26 of 29 nucleotides of the Rx2A transcript (Fig. 3A).
Transgenic embryos were identiﬁed by blue ﬂuorescence generatedXOP). Luciferase assay performed using lysates from embryos co-injected with XOP-Luc
c in a dose-dependent manner. (B) Rx cooperates with otx5b and XLmaf to activate the
rter.
Fig. 3. Generation of Rx knockdown embryos. (A) A portion of X. laevis Rx1A was selected as a target for development of an shRNA. Alignment of the shRNA target sequence with
corresponding regions of X. laevis Rx2A and mouse Rx. (B) Tadpoles transgenic for the Rx shRNA plasmid appeared normal. Bright light or UV-light views of transgenic tadpoles at st
41. (C) Retinas from Rx shRNA transgenic tadpoles appeared histologically normal. Hematoxylin and eosin stained sections of parafﬁn-embedded wild type (left panel) or Rx shRNA
transgenic tadpole. (D) Rx shRNA transgenic tadpoles have reduced levels of both Rx1A and Rx2A as determined by quantitative RT-PCR (qRT-PCR) performed using total RNA
puriﬁed from isolated tadpole heads (st 41). (E) Rx1A is expression is reduced by in situ hybridization performed using 8 μM sections of parafﬁn-embedded tadpoles at st 38, 41, and
45 (from left to right). The reduction in Rx expression appears to increase as development progresses.
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transgene (Fig. 3B). We were surprised to observe no apparent
external or histological phenotype in eye development of embryos
transgenic for the Rx shRNA construct at st 41 (Figs. 3B, C). However,
we found that embryos transgenic for the Rx shRNA construct
exhibited reduced expression of both Rx1A and Rx2A at st 41
(Fig. 3D). Both Rx1A and Rx2A were knocked down approximately
60–90%. Additionally, we found that Rx1A expression in the retina is
essentially normal at st 38 but disappears from the CMZ and
photoreceptor layer by st 41 (Fig. 3E). These results demonstrate
that Rx shRNA transgenic tadpoles can serve as a model in which Rx
expression is reduced in the maturing retina.
As mentioned above, it was curious that shRNA-mediated Rx
knockdown resulted in a late phenotype. We observed that
expression of the cGFP was not readily detectable before st 28 and
intensiﬁed as the tadpoles developed (not shown). These results
suggest that the transgene products may accumulate with time,
resulting in effective knockdown of Rx1A and Rx2A at tadpole stages,
but not before. A second possibility is that the Rx shRNA was
generated during early development but was not functional until
later. One possibility is that the biomolecules involved in either shRNA
processing or function might be in relatively limited supply. The
processing and function of shRNAs is mediated by Argonaute (Ago)
gene products [reviewed in (Faehnle and Joshua-Tor, 2007; Hock andMeister, 2008; Hutvagner and Simard, 2008)]. Ago proteins bind
shRNAs and mediate shRNA–target interactions, including target RNA
degradation. It is possible that expression of the Rx shRNA does not
result in a discernable eye phenotype because the shRNA overwhelms
the system. It has been demonstrated that co-expression of Ago2
enhances the effects of shRNAs in tissue culture (Diederichs et al.,
2008) and in Xenopus tadpoles (Chen et al., 2009). We found that
overexpression of X. laevis Ago2 in Rx shRNA transgenic tadpoles
results in defects in eye development, including anophthalmia and
microophthalmia (Fig. 4A). Eye development defects were not
observed in non-transgenic control tadpoles overexpressing Ago2.
Further, overexpression of Ago2 resulted in decreased Rx expression
in tailbud stage Rx shRNA transgenic embryos (Figs. 4B, C). We
previously did not observe reduction of Rx expression until st 41 (Fig.
3E). These results demonstrate that the effects of the Rx shRNA can be
induced earlier in development by co-expression of the Ago2 gene
product.
We next investigated the effect of decreasing Rx mRNA levels on
putative target gene expression. Rx expression was knocked down
late in development using the Rx shRNA transgene alone. We found
that rho expression was reduced by approximately 50% in Rx shRNA
embryos (Fig. 5A). Additionally, we found that RCO expression was
also reduced by approximately 50% in Rx shRNA transgenic tadpoles.
IRBP and arrestin are additional examples of genes expressed in
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that contain PCE-1 sites. We found that IRBP and arrestin expression
levels are reduced by approximately 75% and 60%, respectively
(Fig. 5A). As a control, we analyzed the expression of silver, a gene
expressed speciﬁcally in the RPE and not the neural retina (Fig. S1).
Silver expression was not reduced in Rx shRNA embryos (Fig. 5A).
Therefore knockdown of Rx expression results in speciﬁc reduction of
expression of photoreceptor genes with regulatory regions that
contain PCE-1 elements.
The results presented above demonstrate that expression of
several genes with PCE-1-containing transcriptional regulatory
regions is dependent on Rx expression. Among these was the rho-
dopsin gene, which contains awell-characterized conserved PCE-1 site
in its promoter. We have demonstrated that the Xenopus rhodopsin
promoter (XOP) can be activated by Rx and can physically interact
with Rx in vivo (Figs. 1D and 2A, B). We next asked if the PCE-1 site
was necessary for regulation of XOP on Rx expression. We prepared
embryos co-transgenic for control or Rx shRNA and a XOP-dsRed
reporter and determined the level of dsRed reporter gene expression
relative to transgene abundance. Consistent with the results pre-
sented above, we found that expression of the dsRed reporter was
reduced by approximately 50% in embryos co-transgenic for Rx shRNA
as compared to control shRNA (Figs. 5B, C). This indicated that the
XOP-dsRed transgene was dependent on Rx for full activity. We then
repeated the experiment using XOP-dsRed containing a mutated PCE-
1 site. We found that expression of the mutated reporter was similar
in embryos co-transgenic for either control or Rx shRNA (Figs. 5B, C).Fig. 4. Exogenous Argonaute2 (Ago2) exacerbates the effects of shRNA-mediated Rx knockd
were generated by intra-cytosolic sperm injection (ICSI) with Rx shRNA transgene and inject
RNA as a lineage tracer. Embryos were photographed under white light (i, ii, iii), red ﬂuore
shRNA transgene (i″, ii″, iii″). Embryos receiving only the Rx shRNA (panels i–iii) or Ago2 R
shRNA and receiving Ago2 RNA in the developing eye exhibited abnormally developed e
expression. Wholemount in situ hybridization using an Rx antisense riboprobe and embry
embryos (i) received neither. These results are presented in graph form in (C).These results demonstrate that the Rx is necessary for normal levels of
rhodopsin promoter activity and that the PCE-1 site is necessary for
this effect. Further, these results indicate that the effects of Rx
knockdown on photoreceptor gene expression are dependent on the
PCE-1 site.
To further investigate the speciﬁcity of shRNA-mediated Rx
knockdown, we undertook a rescue experiment where exogenous
Rx was co-expressed with the Rx shRNA. We chose to express mouse
Rx (mRx) since it contains 12 mismatches in the 32-nucleotide shRNA
target region (Fig. 3A), allowing it to escape knockdown by the Rx
shRNA. We used X. tropicalis Rx regulatory regions to drive speciﬁc
expression of mRx. We combined 3 kb of genomic DNA ﬂanking the
5′-end of the X. tropicalis Rx coding region (tRx3000) with an additional
genomic ultra-conserved element (UCE2) (Fig. 6A). We found that
tRx3000 alonewas capable of driving expression of a GFP transgene in a
similar pattern to endogenous Rx, including the anterior neural plate
and developing eyes at tailbud stages and the photoreceptor layer,
INL, and most of the CMZ of the maturing tadpole retina (Figs. 6B, C).
However, expression was absent from the distal tip of the CMZ, where
Rx is expressed in retinal stem cells (compare Figs. 6Ci and 1A). We
used comparative genomics to identify conserved genomic elements
that may function regulating gene expression. The tRx3000 promoter
contains three UCEs, previously reported as conserved noncoding
sequences (Danno et al., 2008). One of these is located approximately
6 kb upstream of the UCE contained in tRx3000 (UCE3, Fig. 6A). We
ampliﬁed it from genomic DNA and named it UCE2. Addition of UCE2
to tRx3000 (U2 + tRx3000) resulted in additional transgene expressionown. (A) Exogenous Ago2 exacerbates the Rx shRNA knockdown phenotype. Embryos
ed with RNA encoding X. laevis Ago2 RNA. Embryos were co-injected with dsRed Express
scence to visualize dsRed lineage tracer (i′, ii′, iii′), or blue ﬂuorescence to visualize Rx
NA (panels i″–iii″) have apparently normal eyes while embryos transgenic for the Rx
yes (panels i′–iii′). (B) Exogenous Ago2 exacerbates the effects of Rx shRNA on Rx
os receiving either the Rx shRNA transgene (ii), Ago2 RNA (iii), or both (iv). Control
Fig. 5. Photoreceptor gene expression is reduced by Rx knockdown. (A) Expression of the photoreceptor genes rhodopsin, red cone opsin, IRBP, and arrestin are reduced in Rx shRNA
transgenic tadpoles by qRT-PCR, as are Rx1A and Rx2A. Expression of silver is not reduced in Rx shRNA transgenic embryos by qRT-PCR. (B) Rx knockdown results in PCE-1 site-
dependent reduction in rhodopsin promoter activity. Co-transgenic tadpoles were generated using an Rx or control shRNA transgene and XOP-dsRed containing a wild type or
mutated PCE-1 site, as indicated on the left side of the ﬁgure. Left column: retinal cell nuclei visualized using DAPI. Middle column: shRNA transgene visualized by the coral GFP
(cGFP) expression cassette. Right column: XOP-dsRed transgene expression. (C) Quantiﬁcation of results shown in (B) as described in Materials and methods. Rx shRNA results in
reduction of XOP-dsRed as compared to control (reversed sequence) shRNA. Introduction of the Rx shRNA transgene does not result in decreased XOP-dsRed expression level when
the PCE-1 site is mutated. ⁎pb0.025. Abbreviations: WT—wild type; Ctl—control.
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502 Y. Pan et al. / Developmental Biology 339 (2010) 494–506in the distal tip of the CMZ (Fig. 6Cii), similar to the expression of the
endogenous Rx gene. Further characterization of the X. tropicalis Rx
promoter and UCEs will be described elsewhere.
We next prepared transgenic embryos using both the Rx shRNA
and U2 + tRx3000-mRx transgenes (Fig. 6D). These embryos did not
exhibit reduced levels of rho or RCO gene expression (Fig. 6E). TheseFig. 6. Knockdown of photopigment gene expression can be rescued by expression of mouse
the three ultra-conserved elements (UCEs) (UCE2 and UCE3, purple), 3 kb promoter (yellow
UCE2+ tRx3000, containing the 3 kb Rx promoter and UCE2. (B) Expression of tRx3000/GFP tr
ﬂuorescent image of the same embryo shown in (i); (iii) wholemount in situ hybridization
GFP. (C) In situ hybridization of sections of parafﬁn-embedded st 41 tadpoles using an antis
layer, in the INL, and the CMZ. It is not expressed in the distal portion of the CMZ where r
expression throughout the CMZ. (D) Schematic diagram of rescue construct. The construct in
driven by the CMV promoter for selection of transgenic embryos. (E) Expression of photopig
Rx shRNA and the mRx by qRT-PCR.results demonstrate that the effects of Rx knockdown by shRNA can
be restored by expression of mRx and suggest that the effects of Rx
shRNA expression are speciﬁcally a result of reduction or loss of Rx
expression.
Rod development, morphology, and function are dependent on
normal expression, subcellular localization, and function of rhodopsinRx. (A) Top: Schematic diagram of the X. tropicalis Rx genomic locus. Shown are: two of
), ﬁrst coding exon (blue). Bottom: Schematic diagram of Rx regulatory region construct
ansgene in tailbud embryos. (i) white light image of st 20 neural tube stage embryo; (ii)
of tailbud stage (st 28) tRx3000/GFP transgenic embryo using an antisense riboprobe to
ense riboprobe to GFP. (i) The tRx3000/GFP transgene is expressed in the photoreceptor
etinal stem cells are found. (ii) Addition of UCE2 to the tRx3000/GFP transgene drives
cludes themRx coding region driven by UCE2+ tRx3000 and a dsRed expression cassette
ment genes rhodopsin and red cone opsin is not reduced in embryos transgenic for both
Table 2
Visual function test.
Tadpole ST 45 ST 50+
Wild type 100% (10/10) 100% (10/10)
Wild type 100% (10/10) 100% (10/10)
Wild type 100% (10/10) 100% (10/10)
Rx shRNA 1 100% (10/10) 80% (8/10)
Rx shRNA 2 100% (10/10) 40% (4/10)
Rx shRNA 3 100% (10/10) 100% (10/10)
Rx shRNA 4 100% (10/10) 60% (12/20)
Rx shRNA 5 100% (10/10) 60% (12/20)
Rx shRNA + rescue 1 N.D. 90% (18/20)
Rx shRNA + rescue 2 N.D. 90% (17/19)
Rx shRNA + rescue 3 N.D. 95% (18/19)
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(Wilson and Wensel, 2003). We next investigated the downstream
effects of Rx knockdown on photoreceptor histology and function. To
test photoreceptor function, we employed a vision-dependent
behavioral assay that depends on the ﬁnding that tadpoles condi-
tioned to a light colored background prefer a light substratum to a
dark one (Moriya et al., 1996). We found that ﬁve tadpoles transgenic
for the Rx shRNA exhibited normal visual function in this assay at st 45
(Table 2). However, a few days later (st 50), three of ﬁve of these
tadpoles exhibited no preference for substratum color (Table 2),
indicating that vision was impaired in these shRNA transgenic
tadpoles. This result suggests that visual function developed essen-Fig. 7. Speciﬁc degeneration of photoreceptors in visually impaired Rx shRNA tadpoles. (A–
tadpoles. Black arrows indicate nuclei in the outer nuclear layer (ONL). Red arrow indica
embedded tadpoles using an antibody raised against rhodopsin (RetP1). Black arrows indic
staining in the photoreceptor layer. (G–I) Staining of sections prepared from parafﬁn-embed
the photoreceptor layer. Red arrow indicates a gap in PNA staining in the photoreceptor layer
cotransgenic (C, F, I) tadpoles were raised to st 50 and tested for visual function (Table
photoreceptor histology, including missing nuclei (red arrow) compared to a nontransgenic
shRNA and mRx (C). Rod and cone photoreceptors of Rx shRNA tadpoles exhibited reduced
controls (D, E, G, H). Rhodopsin and PNA staining appeared normal in tadpoles transgenictially normal and then deteriorated later. Further, embryos transgenic
for both the Rx shRNA and mRx chose the white substratum,
indicating that visual function was “rescued”. We found that the
vision-impaired tadpoles had abnormal photoreceptors. Photorecep-
tors exhibited abnormal organization andmorphology in these retinas
(Fig. 7B). The outer segments of these photoreceptors were extremely
short and no longer arranged in a parallel manner (compare Fig. 7B to
A). Additionally, the outer nuclear layer was discontinuous (Figs. 7B,
E,H—red arrows). Rods appeared normal in retinas of Rx shRNA
tadpoles that performed normally in the visual function assay (not
shown). We also observed that RPE appeared wavy in affected
embryos, perhaps indicating that the neural retina was reduced
relative to the RPE. Further, rhodopsin expression was reduced in
these tadpoles (Fig. 7E). We also observed abnormalities in cone
development, as visualized by peanut agglutinin (PNA) staining
(Fig. 7H). PNA staining was decreased and discontinuous in Rx shRNA
transgenics relative to nontransgenic controls. Both rods and cones
appeared normal in Rx shRNA mRx co-transgenics (Figs. 7A, D, G).
Visual function, photoreceptor histology, and rod and conemarkers all
appeared normal in tadpoles transgenic for both Rx shRNA and U2 +
tRx3000-mRx (Table 2 and Figs. 7C, F, I). Interestingly, some tadpoles
receiving the Rx shRNA and mRx transgenes had normal cones but
elongated rod photoreceptors (Fig. 7C), suggesting that overexpres-
sion of mRx can result in hyperdevelopment of photoreceptors. Taken
together, these results demonstrate that the development of normal
photoreceptor structure and function require normal Rx expression.C) Hematoxylin and eosin staining of sections prepared from parafﬁn-embedded st 50
tes a gap in the ONL. (D–F) Immunohistochemical staining of sections from parafﬁn-
ate RetP1-positive cells in the photoreceptor layer. Red arrow indicates a gap in RetP1
ded tadpoles using peanut agglutinin (PNA). Black arrows indicate PNA-positive cells in
.Wild type (A, D, G), Rx shRNA transgenic (B, E, H), or Rx shRNA+mRx rescue construct
1). Rx shRNA transgenic tadpoles with impaired visual function exhibited abnormal
control (A, B). Photoreceptor histology was normal in a tadpole transgenic for both Rx
staining with rhodopsin and PNA (red arrows in E and H) compared to nontransgenic
for both the Rx shRNA and mRx (F, I).
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In this paper we presented data demonstrating that Rx gene
products play a role in regulating PCE-1-containing promoters. It has
been demonstrated that zebraﬁsh Rx gene products are necessary for
normal photoreceptor development and expression of normal levels
of markers of differentiated photoreceptors (Nelson et al., 2009). We
have provided evidence that Rx may directly regulate expression of
PCE-1-dependent genes.
It is not entirely surprising that Rx may play a role in promoting
transcription of photoreceptor genes. We and others have previously
characterized the activity of Rx-like gene products (Ohuchi et al.,
1999; Pan et al., 2006; Wang et al., 2004; Wu et al., 2009). These gene
products are expressed during photoreceptor differentiation and
function as stronger transcriptional activators than Rx. However, mice
do not have an Rx-like gene (Wang et al., 2004). This suggests that Rx
may play the role of Rx-like gene products in mice in regulating
promoters containing PCE-1 sites. If this is the case, then Rx may also
play a role in regulating those target genes in species that express an
Rx-like gene product. However, it is not clear how Rx function is
modiﬁed by the co-expression of an Rx-like gene product in
photoreceptors.
It has been suggested that Rx may bind to homeobox response
elements in the rhodopsin promoter in addition to the PCE-1 site
(Wang et al., 2004). It has been demonstrated that Rx can bind the
BAT site with reduced afﬁnity (Kimura et al., 2000). We have
demonstrated that Rx can bind both the BAT and Ret4 sites, albeit
with lower afﬁnity than the PCE-1 site (Pan et al., 2006). In this work,
we demonstrated that knockdown of Rx expression results in reduced
expression of rhodopsin and a rhodopsin promoter reporter (XOP-
dsRed). However, Rx knockdown did not affect expression of the
reporter when the PCE-1 site was mutated. This result indicates that
Rx does not regulate transcription appreciably through the BAT or
Ret4 sites in vivo. Therefore Rx regulates rhodopsin promoter activity
primarily through the PCE-1 site.
Expression of mRx in Rx knockdown rescued retinal development,
maintenance, and function. Interestingly, these embryos exhibited
normal-appearing cones but elongated rods. This suggests that mRx
and endogenous Rx1A/Rx2A may not be functionally equivalent. As
discussed above, mRx must functionally replace Rx-like transcrip-
tional activators that are absent from the mouse genome. Therefore, it
is possible that this dual functionality results in hyperdeveloped rod
photoreceptors. Alternatively, there may be other functional differ-
ences between mRx and frog Rx orthologs aside from strength of
transactivation. Mammalian and Xenopus Rx proteins are highly
conserved in the major domains shared among aristaless-related
paired type homeobox proteins (octapeptide, homeodomain, OAR
domain), but also contain regions of relative divergence. It is possible
that these less well-conserved domains contribute to putative
functional differences between mouse and frog Rx.
Our results suggest that Rx may have a role in promoting
photoreceptor differentiation in the maturing retina in cooperation
with crx/otx5b and Nrl/XLmaf. Additional factors are involved in rho
promoter regulation in vivo. For example, mammalian rho promoters
are also regulated by the zinc ﬁnger proteins Sp4 (Lerner et al., 2005)
and KLF15 (Otteson et al., 2004) and the nuclear hormone receptors
Nr2e3 and Nr1d1 (Cheng et al., 2004). It will be interesting to
investigate whether Rx can also cooperate with these additional
factors or how Rx interaction with otx5b/Crx and XLmaf/Nrl might be
affected by their inclusion.
Rx is already well known for its essential role during retinal
speciﬁcation very early in eye development. Thus the intriguing
question arises: does Rx function differ during fundamentally
different phases of retinal speciﬁcation and maturation? It is likely
that Rx interacts with different transcription factors when regulating
target genes early vs. late in retinal development, especially sincetranscription factors associated with photoreceptor differentiation,
such as Crx and Nrl, are not expressed during early phases of
mammalian retinal development (Chen et al., 1997; Furukawa et al.,
1997b; Swaroop et al., 1992). However, the deﬁnitive answer to this
question awaits ﬁne characterization of bona ﬁde Rx target promoters
that regulate transcription prior to the onset of expression of
photoreceptor-speciﬁc genes such as opsins.
It has been suggested that the transcription factor that binds the
PCE-1 site must function as a transcriptional repressor since deletion
of the site results in an increase in opsin promoter activity (Mani et al.,
2001). This is in apparent contradiction to the function of Rx as a
transcriptional activator, discussed above. It has been proposed that
Rx may repress opsin promoter activity in vivo since it is primarily
expressed early in development, before the onset of opsin gene
expression. However, Rx expression has been reported in the
maturing Xenopus retina (Perron et al., 1998 and this work) and in
mature photoreceptors in the zebraﬁsh retina (Chuang et al., 1999).
Additionally, Rx-like gene products are expressed in developing
photoreceptors. QRX and Erx have been identiﬁed as additional gene
products that bind to PCE-1 sites in cDNA library screens (Martinez
and Barnstable, 1998; Wang et al., 2004). QRX and other Rx-like gene
products, chicken cRaxL and Xenopus Rx-L, share a conserved
homeodomain and OAR domain with Rx but differ elsewhere (Chen
and Cepko, 2002; Ohuchi et al., 1999; Pan et al., 2006; Wang et al.,
2004). Little is known about Erx aside from its partial sequence and
expression in photoreceptors. Recently, it has been demonstrated that
another retinal paired-type homeobox protein, Chx10/Vsx2, also
binds the PCE-1 site (Dorval et al., 2006). Thus, it seems that the
results from previous XOP PCE-1 mutagenesis experiments might
represent the regulation of reporters by multiple PCE-1-binding
proteins (Rx, QRX/RxL, Erx, Vsx). While Rx and Rx-like gene products
are expressed in photoreceptors, Chx10/Vsx2 is expressed in a subset
of bipolar cells. This is consistent with Rx and Rx-like gene products
playing a role in enhancing photoreceptor-speciﬁc gene expression.
Additionally, Chx10/Vsx2 and other PCE-1 binding gene products
may lend speciﬁcity to PCE-1-dependent gene expression by repres-
sing photoreceptor-speciﬁc gene expression outside of the photore-
ceptor layer.
Knockdownof Rx expression resulted in a decrease in photoreceptor
gene expression and led to a reduction in vision and abnormal
photoreceptor arrangement and morphology. These deﬁcits were
observed later in tadpole development (st 50+ as opposed to st 45),
reminiscent of retinal degeneration. Several retinal degeneration
diseases are caused by mutations in rhodopsin that result in its
mislocalization and eventual interference in normal photoreceptor
function but not a reduction in rhodopsin expression levels (Wilson and
Wensel, 2003). Additionally, mutations in IRBP or arrestin genes are
found in patients with retinitis pigmentosa, a progressive retinal
dystrophy (den Hollander et al., 2009; Nakazawa et al., 1998; Valverde
et al., 1998). However, in the case of our Rx shRNA tadpoles, expression
levels of many photoreceptor-speciﬁc genes (potentially every gene
with a PCE-1-dependent promoter/enhancer) are being reduced
simultaneously. The effects of reduction or loss of expression of every
PCE-1-dependent gene product is unknown. However, since many, if
not most, photoreceptor-speciﬁc genes contain conserved PCE-1 sites
within regulatory regions, it is easy to imagine that knockdown of these
gene products would be catastrophic to the development, maintenance,
function, and integrity of photoreceptor cells.
Knockdown of Rx expression using translation-inhibitory anti-
sense morpholino oligonucleotides results in anophthalmia (Pan and
El-Hodiri, unpublished and Bailey et al., 2004), similar to the
phenotype of Rx knock-out mice and Rx mutant ﬁsh (Loosli et al.,
2003, 2001; Mathers et al., 1997). We expect the Rx shRNA transcript
to be present frommid-blastula stages but did not observe signiﬁcant
reduction in Rx1A transcript levels by Rx shRNA until retinal
maturation stages (after st 38). This explains how the retina is able
505Y. Pan et al. / Developmental Biology 339 (2010) 494–506to form essentially normally in these embryos. It is possible that the
Rx shRNA is produced but does not accumulate to sufﬁciently high
concentrations to affect Rx expression until relatively late stages
allowing early eye development to proceed normally. Alternatively, it
is possible that shRNA is produced but is not functional until later
stages. It has been reported that knockdown of dicer expression
results perturbs retinal development beginning at approximately st
30 (Decembrini et al., 2008). The lack of functional Rx shRNA would
allow early eye development to escape the effects of knockdown and
only later development would be affected. Indeed, we demonstrated
that Rx shRNA embryos exhibit eye defects earlier in development
when exogenous Argonaute 2 (Ago2) is also expressed. This suggests
that RxshRNA is produced early but is not functional until later stages
without additional Argonaute expression. As discussed by Chen et al.
(2009), manipulation of spatial and temporal expression of shRNA
and Ago2 allows speciﬁc spatial and temporal control of gene
knockdown. shRNA and Ago2-mediated knockdown can be regulated
by the use of tissue- or developmental stage-speciﬁc promoters or
inducible forms of these reagents.
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